Senate Finance Committee Releases Insulin Investigation Results
In the midst of the chaos in Washington, D.C. in January 2021, the United States Senate Finance Committee released the results of…
Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Yearly Archives
2021
Fifth Circuit Upholds FTC Ruling on Impax Antitrust Violations
On April 13, 2021, the United States Court of Appeals for the Fifth Circuit denied a Petition for Review filed by Impax…
Sanofi Awarded Attorney Fees in “Frivolous” False Claims Act Suit
Some readers may remember the False Claims Act lawsuit filed by Amphastar Pharmaceuticals Inc. (Amphastar) against Sanofi-Aventis,…
CMS Announces Changes to Part D Payment Modernization Model
The Biden administration has walked back a last-minute bid by its predecessor to give Medicare Part D plans the ability to…
ACPE Offers Resources to Support Transition to ACCME Standards
The Accreditation Council for Pharmacy Education recently added tools and resources to its website to support the new…
HHS Releases New Buprenorphine Practice Guidelines
Recently, the United States Department of Health and Human Services (HHS) released new buprenorphine practice guidelines, Practice…
Six Individuals Sentenced for Their Roles in Anti-Kickback and Fraud…
Six individuals were recently sentenced for their connection to multiple health care fraud conspiracies involving kickbacks and…
DOJ Announces $12.6 Million Settlement with Incyte Corporation
On May 4, 2021, the United States Department of Justice announced a $12.6 million settlement with Incyte Corporation, resolving…
Bristol-Myers Squibb Pays $75 Million to Resolve False Claims Act…
Bristol-Myers Squibb (BMS) recently came to an agreement with the United States and participating states to pay $75 million plus…
What Does Secretary Becerra Mean for Drug Prices?
In March, the U.S. Senate voted to confirm Xavier Becerra as secretary of the Department of Health and Human Services despite…